Work

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

Year: 1999

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: J Baselga, D Tripathy, J Mendelsohn, S Baughman, C C Benz, L Dantis, N T Sklarin, A D Seidman, C A Hudis, J Moore, P P Rosen, T Twaddell, I C Henderson, L Norton

Institutions: Memorial Sloan Kettering Cancer Center, Universitat Autònoma de Barcelona

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: SPORE in Breast Cancer

OpenAlex ID: W2285386092

FWCI: 11.11

Cites:

Cited by: 299

Related to: 10